Exagen Inc.
XGN
$6.43
-$0.45-6.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -0.80% | -6.78% | 6.56% | 28.36% | 7.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.80% | -6.78% | 6.56% | 28.36% | 7.23% |
| Cost of Revenue | -7.86% | -3.22% | 2.95% | -1.84% | -10.92% |
| Gross Profit | 4.08% | -9.41% | 9.10% | 62.10% | 24.77% |
| SG&A Expenses | -16.47% | -10.65% | -12.46% | -11.29% | -4.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.91% | -7.11% | -7.35% | -8.02% | -11.73% |
| Operating Income | 34.27% | 8.01% | 47.37% | 61.03% | 40.07% |
| Income Before Tax | 32.33% | 7.15% | 40.83% | 56.30% | 62.15% |
| Income Tax Expenses | -63.64% | -- | -- | -- | 111.70% |
| Earnings from Continuing Operations | 32.51% | 7.15% | 40.83% | 56.30% | 61.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 32.51% | 7.15% | 40.83% | 56.30% | 61.17% |
| EBIT | 34.27% | 8.01% | 47.37% | 61.03% | 40.07% |
| EBITDA | 36.03% | 5.00% | 51.09% | 64.42% | 42.49% |
| EPS Basic | 34.69% | 10.03% | 42.51% | 57.32% | 62.57% |
| Normalized Basic EPS | 34.47% | 10.04% | 42.54% | 57.33% | 38.85% |
| EPS Diluted | 34.69% | 10.03% | 42.51% | 57.32% | 62.57% |
| Normalized Diluted EPS | 34.47% | 10.04% | 42.54% | 57.33% | 38.85% |
| Average Basic Shares Outstanding | 3.32% | 3.18% | 2.96% | 2.38% | 3.73% |
| Average Diluted Shares Outstanding | 3.32% | 3.18% | 2.96% | 2.38% | 3.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |